Martingale Asset Management L P Jazz Pharmaceuticals PLC Transaction History

Martingale Asset Management L P

$4.02 Billion
Q2 2025

A detailed history of Martingale Asset Management L P transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Martingale Asset Management L P holds 2,507 shares of JAZZ stock, worth $349,300. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,507

Previous 8,641 70.99%

Holding current value

$349,300

Previous $1.07 Million 75.19%

% of portfolio

0.01%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$97.78 - $126.44 $599,782 - $775,582	-6,134 Reduced 70.99%	2,507 $266,000
Q1 2025 May 14, 2025	BUY	$120.07 - $144.17 $559,045 - $671,255	4,656 Added 116.84%	8,641 $1.07 Million
Q4 2024 Feb 13, 2025	SELL	$107.32 - $127.74 $169,994 - $202,340	-1,584 Reduced 28.44%	3,985 $490,000
Q3 2024 Nov 14, 2024	BUY	$100.57 - $116.37 $367,080 - $424,750	3,650 Added 190.2%	5,569 $620,000
Q2 2024 Aug 12, 2024	SELL	$103.94 - $118.98 $469,185 - $537,075	-4,514 Reduced 70.17%	1,919 $204,000
Q1 2024 May 14, 2024	SELL	$115.19 - $132.77 $33,865 - $39,034	-294 Reduced 4.37%	6,433 $774,000
Q4 2023 Feb 12, 2024	SELL	$114.26 - $136.0 $6.3 Million - $7.5 Million	-55,114 Reduced 89.12%	6,727 $827,000
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $2.23 Million - $2.65 Million	-18,267 Reduced 22.8%	61,841 $8 Million
Q2 2023 Aug 11, 2023	SELL	$122.5 - $147.16 $2.14 Million - $2.56 Million	-17,429 Reduced 17.87%	80,108 $9.93 Million
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $603,981 - $723,398	-4,508 Reduced 4.42%	97,537 $14.3 Million
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $1.5 Million - $1.85 Million	11,557 Added 12.77%	102,045 $16.3 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $4.92 Million - $6.26 Million	38,828 Added 75.16%	90,488 $12.1 Million
Q2 2022 Aug 11, 2022	BUY	$141.59 - $168.66 $7.1 Million - $8.46 Million	50,136 Added 3289.76%	51,660 $8.06 Million
Q1 2022 May 12, 2022	BUY	$129.64 - $160.7 $197,571 - $244,906	1,524 New	1,524 $237,000
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $23.4 Million - $33.6 Million	-181,625 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $3.78 Million - $4.4 Million	-23,617 Reduced 11.51%	181,625 $32.3 Million
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $8.64 Million - $9.98 Million	-57,526 Reduced 21.89%	205,242 $33.7 Million
Q4 2020 Feb 10, 2021	SELL	$140.71 - $165.05 $3.49 Million - $4.09 Million	-24,772 Reduced 8.62%	262,768 $43.4 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $3.45 Million - $4.72 Million	-32,752 Reduced 10.23%	287,540 $41 Million
Q2 2020 Aug 10, 2020	SELL	$95.68 - $121.88 $289,623 - $368,930	-3,027 Reduced 0.94%	320,292 $35.3 Million
Q1 2020 May 11, 2020	SELL	$87.74 - $152.74 $2.59 Million - $4.51 Million	-29,520 Reduced 8.37%	323,319 $32.2 Million
Q4 2019 Feb 10, 2020	SELL	$117.65 - $153.73 $3.32 Million - $4.34 Million	-28,215 Reduced 7.4%	352,839 $52.7 Million
Q3 2019 Nov 13, 2019	BUY	$125.18 - $143.24 $4.98 Million - $5.69 Million	39,757 Added 11.65%	381,054 $48.8 Million
Q2 2019 Aug 13, 2019	BUY	$125.55 - $144.48 $2.56 Million - $2.95 Million	20,421 Added 6.36%	341,297 $0
Q1 2019 May 08, 2019	BUY	$121.81 - $142.95 $9.69 Million - $11.4 Million	79,521 Added 32.95%	320,876 $0
Q4 2018 Feb 11, 2019	BUY	$115.94 - $166.74 $7.75 Million - $11.1 Million	66,839 Added 38.3%	241,355 $29.9 Million
Q3 2018 Nov 09, 2018	BUY	$161.01 - $180.57 $27.8 Million - $31.2 Million	172,913 Added 10786.84%	174,516 $0
Q2 2018 Aug 09, 2018	BUY	$146.33 - $183.18 $234,566 - $293,637	1,603 New	1,603 $0

Others Institutions Holding JAZZ

# of Institutions

565

Shares Held

62.4M

Call Options Held

563K

Put Options Held

77.8K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.73B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Jazz Pharmaceuticals PLC Transaction History